0001104659-19-047287.txt : 20190826
0001104659-19-047287.hdr.sgml : 20190826
20190826161848
ACCESSION NUMBER: 0001104659-19-047287
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190822
FILED AS OF DATE: 20190826
DATE AS OF CHANGE: 20190826
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wedell-Wedellsborg Johan
CENTRAL INDEX KEY: 0001753185
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 191053161
MAIL ADDRESS:
STREET 1: RUNGSTED STRANDVEJ 113
CITY: RUNGSTED KYST
STATE: G7
ZIP: 2960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
a4.xml
4
X0306
4
2019-08-22
0
0001722964
Y-mAbs Therapeutics, Inc.
YMAB
0001753185
Wedell-Wedellsborg Johan
C/O WECO GROUP A/S
RUNGSTED STRANDVEJ 113
RUNGSTED KYST
G7
2960
DENMARK
1
0
1
0
Common Stock
2019-08-22
4
S
0
990
27.75
D
654158
I
By Weco Group A/S
Reporting Person is the majority owner of Weco Group A/S and as such has sole voting and dispositive power with respect to such shares.
/s/ Johan Wedell-Wedellsborg
2019-08-26